cycloheximide has been researched along with hippuristanol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Appleman, JR; Chen, J; Chiang, GG; Clarine, J; Eam, B; Ernst, JT; Fish, S; Howard, H; Michels, T; Molter, J; Nevarez, A; Nilewski, C; Packard, G; Reich, SH; Sperry, S; Sprengeler, PA; Staunton, J; Thompson, PA; Tran, C; Webster, KR; Wegerski, CJ; Xiang, A; Young, NP | 1 |
Arosio, P; Hondele, M; Linsenmeier, M; Mugler, CF; Sachdev, R; Vallotton, P; Weis, K | 1 |
2 other study(ies) available for cycloheximide and hippuristanol
Article | Year |
---|---|
Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.
Topics: Animals; Benzofurans; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Eukaryotic Initiation Factor-4A; Female; Half-Life; Humans; Ligands; Mice; Mice, Nude; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Protein Structure, Tertiary; Rats; RNA, Messenger; Structure-Activity Relationship | 2020 |
Pat1 promotes processing body assembly by enhancing the phase separation of the DEAD-box ATPase Dhh1 and RNA.
Topics: Cycloheximide; Cytoplasmic Granules; DEAD-box RNA Helicases; Mutation; Phosphorylation; Protein Binding; RNA-Binding Proteins; RNA, Fungal; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sterols | 2019 |